Aquestive Therapeutics, Inc.

Warner-lambert Company

Novartis Ag

Monosol Rx, LLC

Midatech Limited

Novartis Consumer Health S.a.

Alexander Mark Schobel

Stephen Paul Wargacki

Stephanie Marie Varjan

Thomas William Rademacher

Lori D Kumar

Phillip Williams

Peter Boyd

John Maxwell

Ronald Lee Dahl

Theresa Wood

Monte Lee Friesen

Vincent J Buono

Susan Shumard

Nils William Ahlgren

Christopher James Santee

Keith Kendall

Dan Barber

Robert K Yang

Eric Dadey

Robert W Schumacher

Keith Joseph Kendall

Garry L Myers

Beuford A Bogue

John Denick, Jr

Jan Mous

Stanley Lech

Isabelle Rault

Greg Slominski

Africa Garcia Barrientos

Raymond L Mohrle

Stephan Meyer

Allen H Heller

Shyam S Vangala

Justin N W Barry

Gavin Murray Spencer

Daniel R Barber

Justin Nw Barry

Gary Saltko

Shyam Sundar Kumar Sarma Vangala

A method of administering diazepam having a food effect is described.

Oral and nasal compositions and methods of treatment

Pharmaceutical compositions having enhanced active component permeation properties are described.

Enhanced delivery epinephrine and prodrug compositions

Enhanced delivery epinephrine compositions

An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.

Oral film compositions and dosage forms having precise active dissolution profiles

Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.

System and method for making personalized individual unit doses containing pharmaceutical actives

Pharmaceutical compositions with enhanced permeation

Nanoparticles having a core and a corona of ligands covalently linked to the core, wherein differing species of peptides are bound to the nanoparticles and incorporated into various dosage forms.

Combination peptide-nanoparticles and delivery systems incorporating same

A solid dosage form containing a taste masked active agent is provided. The solid dosage form may be provided as a water soluble film that is disintegrable in the oral cavity to deliver and release the taste masked active agent. The disintegrable film includes at least one water soluble polymer and a taste masked ketoprofen active. Also provided are methods for preparing the solid dosage form and for using the solid dosage to administer an effective dosage of an active agent, such as ketoprofen, into the oral cavity for absorption.

Solid dosage form containing a taste masked active agent

A therapeutic or bioeffecting film delivery system which includes nanoparticles having actives bound to or associated with the nanoparticles and which when administered allow the active to perform a therapeutic or bioeffecting function.

Nanoparticle film delivery systems

Growing community of inventors

Whitehouse Station, NJ, United States of America

Alexander Mark Schobel